These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7024242)

  • 1. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
    Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
    J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
    Dijkmans BA; Vaishnav J; Mattie H
    J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal activities and morphologic changes in Escherichia coli and Bacteroides fragilis by cephalosporins.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Satoh M; Kai J; Tamaya T
    Chemotherapy; 1998; 44(3):157-63. PubMed ID: 9612605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of antimicrobial activity of metronidazole in mixed cultures of Bacteroides fragilis and Escherichia coli.
    Moran FJ; Perez C; Hurtado C; Blanco MT; Prieto J
    J Antimicrob Chemother; 1988 Aug; 22(2):261-2. PubMed ID: 3053557
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterial synergy in mixed aerobic/anaerobic infections.
    Ingham HR; Selkon JB; Sisson PR; Middleton RL
    Lancet; 1980 Mar; 1(8169):659-60. PubMed ID: 6102668
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
    Beale AS; Gisby J; Sutherland R
    J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteroides fragilis resistant to metronidazole after long-term therapy.
    Ingham HR; Eaton S; Venables CW; Adams PC
    Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteroides fragilis resistant to both metronidazole and imipenem.
    Lamothe F; Fijalkowski C; Malouin F; Bourgault AM; Delorme L
    J Antimicrob Chemother; 1986 Nov; 18(5):642-3. PubMed ID: 3468099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.